One study found that immune stromal expression of 5-LOX was increased in ovarian cancer tissues, suggesting a role of 5-LOX signaling specifically in the tumor microenvironment during ovarian cancer development and progression (46). Here, ALOX5 is linked to ovarian carcinoma.